Current opinion in obstetrics & gynecology
[No authors listed]
PMID: 1450361
Curr Opin Obstet Gynecol. 1992 Dec;4(6):943-9.
No abstract available.
Cite
Office gynecology. Curr Opin Obstet Gynecol. 1992;4(6):943-9
(1992). Office gynecology. Current opinion in obstetrics & gynecology, 4(6), 943-9.
"Office gynecology." Current opinion in obstetrics & gynecology vol. 4,6 (1992): 943-9.
Office gynecology. Curr Opin Obstet Gynecol. 1992 Dec;4(6):943-9. PMID: 1450361.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Lu MC.
PMID: 18989132
Curr Opin Obstet Gynecol. 2008 Dec;20(6):563-5. doi: 10.1097/GCO.0b013e328318eadc.
No abstract available.
Cite
Lu MC. We can do better: improving women's health in America. Curr Opin Obstet Gynecol. 2008;20(6):563-5doi: 10.1097/GCO.0b013e328318eadc.
Lu, M. C. (2008). We can do better: improving women's health in America. Current opinion in obstetrics & gynecology, 20(6), 563-5. https://doi.org/10.1097/GCO.0b013e328318eadc
Lu, Michael C. "We can do better: improving women's health in America." Current opinion in obstetrics & gynecology vol. 20,6 (2008): 563-5. doi: https://doi.org/10.1097/GCO.0b013e328318eadc
Lu MC. We can do better: improving women's health in America. Curr Opin Obstet Gynecol. 2008 Dec;20(6):563-5. doi: 10.1097/GCO.0b013e328318eadc. PMID: 18989132.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Farquhar C, Vail A.
PMID: 16794425
Curr Opin Obstet Gynecol. 2006 Aug;18(4):433-9. doi: 10.1097/01.gco.0000233939.44178.4b.
PURPOSE OF REVIEW: The term 'evidence-based medicine' means integrating individual clinical expertise with the best available external clinical evidence from systematic research. An important source for those who wish to practise evidence-based medicine is the systematic review. Systematic reviews,...
Cite
Farquhar C, Vail A. Pitfalls in systematic reviews. Curr Opin Obstet Gynecol. 2006;18(4):433-9doi: 10.1097/01.gco.0000233939.44178.4b.
Farquhar, C., & Vail, A. (2006). Pitfalls in systematic reviews. Current opinion in obstetrics & gynecology, 18(4), 433-9. https://doi.org/10.1097/01.gco.0000233939.44178.4b
Farquhar, Cynthia, and Vail, Andy. "Pitfalls in systematic reviews." Current opinion in obstetrics & gynecology vol. 18,4 (2006): 433-9. doi: https://doi.org/10.1097/01.gco.0000233939.44178.4b
Farquhar C, Vail A. Pitfalls in systematic reviews. Curr Opin Obstet Gynecol. 2006 Aug;18(4):433-9. doi: 10.1097/01.gco.0000233939.44178.4b. PMID: 16794425.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Karre I.
PMID: 23138437
Curr Opin Obstet Gynecol. 2012 Dec;24(6):440-4. doi: 10.1097/GCO.0b013e328359f061.
PURPOSE OF REVIEW: The purpose of this review is to explore pathways and develop specific knowledge and skills for leading teams that thrive. Here we will discuss current research findings and specific strategies you can use to create stronger...
Cite
Karre I. Leading teams that thrive. Curr Opin Obstet Gynecol. 2012;24(6):440-4doi: 10.1097/GCO.0b013e328359f061.
Karre, I. (2012). Leading teams that thrive. Current opinion in obstetrics & gynecology, 24(6), 440-4. https://doi.org/10.1097/GCO.0b013e328359f061
Karre, Idahlynn. "Leading teams that thrive." Current opinion in obstetrics & gynecology vol. 24,6 (2012): 440-4. doi: https://doi.org/10.1097/GCO.0b013e328359f061
Karre I. Leading teams that thrive. Curr Opin Obstet Gynecol. 2012 Dec;24(6):440-4. doi: 10.1097/GCO.0b013e328359f061. PMID: 23138437.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Nakamura S.
PMID: 23425664
Curr Opin Obstet Gynecol. 2013 Feb 19; doi: 10.1097/GCO.0b013e32834f3608. Epub 2013 Feb 19.
PURPOSE OF REVIEW: Sentinel lymph node biopsy (SLNB) has become a gold standard procedure for axillary lymph node evaluation in clinically node-negative patients. In those patients with positive SLNB, completion axillary lymph node dissection (ALND) has been routely performed....
Cite
Nakamura S. Axillary lymph node dissection in sentinel node positive breast cancer: is it necessary?. Curr Opin Obstet Gynecol. 2013;doi: 10.1097/GCO.0b013e32834f3608.
Nakamura, S. (2013). Axillary lymph node dissection in sentinel node positive breast cancer: is it necessary?. Current opinion in obstetrics & gynecology, . https://doi.org/10.1097/GCO.0b013e32834f3608
Nakamura, Seigo. "Axillary lymph node dissection in sentinel node positive breast cancer: is it necessary?." Current opinion in obstetrics & gynecology vol. (2013). doi: https://doi.org/10.1097/GCO.0b013e32834f3608
Nakamura S. Axillary lymph node dissection in sentinel node positive breast cancer: is it necessary?. Curr Opin Obstet Gynecol. 2013 Feb 19; doi: 10.1097/GCO.0b013e32834f3608. Epub 2013 Feb 19. PMID: 23425664.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
O'Keeffe DF.
PMID: 23090618
Curr Opin Obstet Gynecol. 2012 Dec;24(6):436-9. doi: 10.1097/GCO.0b013e328359b605.
PURPOSE OF REVIEW: To discuss leadership.RECENT FINDINGS: Leadership in healthcare has many similarities to other industries.SUMMARY: Given that now is a time of great transition in healthcare, leadership in healthcare is needed now more than ever from physicians. However,...
Cite
O'Keeffe DF. Leadership. Curr Opin Obstet Gynecol. 2012;24(6):436-9doi: 10.1097/GCO.0b013e328359b605.
O'Keeffe, D. F. (2012). Leadership. Current opinion in obstetrics & gynecology, 24(6), 436-9. https://doi.org/10.1097/GCO.0b013e328359b605
O'Keeffe, Daniel F. "Leadership." Current opinion in obstetrics & gynecology vol. 24,6 (2012): 436-9. doi: https://doi.org/10.1097/GCO.0b013e328359b605
O'Keeffe DF. Leadership. Curr Opin Obstet Gynecol. 2012 Dec;24(6):436-9. doi: 10.1097/GCO.0b013e328359b605. PMID: 23090618.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Blumenthal PD.
PMID: 34747878
Curr Opin Obstet Gynecol. 2021 Dec 01;33(6):431-432. doi: 10.1097/GCO.0000000000000752.
No abstract available.
Cite
Blumenthal PD. Editorial: Updates in contraception and abortion care: reviews from both the clinical and social science sides of the aisle. Curr Opin Obstet Gynecol. 2021;33(6):431-432doi: 10.1097/GCO.0000000000000752.
Blumenthal, P. D. (2021). Editorial: Updates in contraception and abortion care: reviews from both the clinical and social science sides of the aisle. Current opinion in obstetrics & gynecology, 33(6), 431-432. https://doi.org/10.1097/GCO.0000000000000752
Blumenthal, Paul D. "Editorial: Updates in contraception and abortion care: reviews from both the clinical and social science sides of the aisle." Current opinion in obstetrics & gynecology vol. 33,6 (2021): 431-432. doi: https://doi.org/10.1097/GCO.0000000000000752
Blumenthal PD. Editorial: Updates in contraception and abortion care: reviews from both the clinical and social science sides of the aisle. Curr Opin Obstet Gynecol. 2021 Dec 01;33(6):431-432. doi: 10.1097/GCO.0000000000000752. PMID: 34747878.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Kaur S, Blumenthal PD.
PMID: 34747882
Curr Opin Obstet Gynecol. 2021 Dec 01;33(6):458-462. doi: 10.1097/GCO.0000000000000757.
PURPOSE OF REVIEW: Myths and misconceptions about family planning are pervasive around the world and can adversely affect both initiation and continuation of family planning services. Here, we review the current literature and identify major themes among them to...
Cite
Kaur S, Blumenthal PD. Global myth busting in family planning. Curr Opin Obstet Gynecol. 2021;33(6):458-462doi: 10.1097/GCO.0000000000000757.
Kaur, S., & Blumenthal, P. D. (2021). Global myth busting in family planning. Current opinion in obstetrics & gynecology, 33(6), 458-462. https://doi.org/10.1097/GCO.0000000000000757
Kaur, Simranvir, and Blumenthal, Paul D. "Global myth busting in family planning." Current opinion in obstetrics & gynecology vol. 33,6 (2021): 458-462. doi: https://doi.org/10.1097/GCO.0000000000000757
Kaur S, Blumenthal PD. Global myth busting in family planning. Curr Opin Obstet Gynecol. 2021 Dec 01;33(6):458-462. doi: 10.1097/GCO.0000000000000757. PMID: 34747882.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
McAndrew NP.
PMID: 34967814
Curr Opin Obstet Gynecol. 2022 Feb 01;34(1):41-45. doi: 10.1097/GCO.0000000000000762.
PURPOSE OF REVIEW: To highlight recent practice changing clinical trials, focusing on those leading to new drug approvals, in human epidermal growth factor receptor 2-positive (HER2+) breast cancer.RECENT FINDINGS: The improved disease-free survival of adjuvant trastuzumab emtansine (T-DM1) over...
Cite
McAndrew NP. Updates on targeting human epidermal growth factor receptor 2-positive breast cancer: what's to know in 2021. Curr Opin Obstet Gynecol. 2022;34(1):41-45doi: 10.1097/GCO.0000000000000762.
McAndrew, N. P. (2022). Updates on targeting human epidermal growth factor receptor 2-positive breast cancer: what's to know in 2021. Current opinion in obstetrics & gynecology, 34(1), 41-45. https://doi.org/10.1097/GCO.0000000000000762
McAndrew, Nicholas P. "Updates on targeting human epidermal growth factor receptor 2-positive breast cancer: what's to know in 2021." Current opinion in obstetrics & gynecology vol. 34,1 (2022): 41-45. doi: https://doi.org/10.1097/GCO.0000000000000762
McAndrew NP. Updates on targeting human epidermal growth factor receptor 2-positive breast cancer: what's to know in 2021. Curr Opin Obstet Gynecol. 2022 Feb 01;34(1):41-45. doi: 10.1097/GCO.0000000000000762. PMID: 34967814.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Haji F, Baker JL, DiNome ML.
PMID: 34545016
Curr Opin Obstet Gynecol. 2022 Feb 01;34(1):46-51. doi: 10.1097/GCO.0000000000000753.
PURPOSE OF REVIEW: Ductal carcinoma in situ (DCIS) is a noninvasive stage of disease but understood to be a nonobligate precursor to invasive breast cancer. As such, women with DCIS are routinely recommended for standard breast cancer treatment to...
Cite
Haji F, Baker JL, DiNome ML. Updates on treating ductal carcinoma in situ: what's to know in 2021. Curr Opin Obstet Gynecol. 2022;34(1):46-51doi: 10.1097/GCO.0000000000000753.
Haji, F., Baker, J. L., & DiNome, M. L. (2022). Updates on treating ductal carcinoma in situ: what's to know in 2021. Current opinion in obstetrics & gynecology, 34(1), 46-51. https://doi.org/10.1097/GCO.0000000000000753
Haji, Farnaz, et al. "Updates on treating ductal carcinoma in situ: what's to know in 2021." Current opinion in obstetrics & gynecology vol. 34,1 (2022): 46-51. doi: https://doi.org/10.1097/GCO.0000000000000753
Haji F, Baker JL, DiNome ML. Updates on treating ductal carcinoma in situ: what's to know in 2021. Curr Opin Obstet Gynecol. 2022 Feb 01;34(1):46-51. doi: 10.1097/GCO.0000000000000753. PMID: 34545016.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Manrriquez EN, Zakhour M, Salani R.
PMID: 34596094
Curr Opin Obstet Gynecol. 2022 Feb 01;34(1):1-5. doi: 10.1097/GCO.0000000000000755.
PURPOSE OF REVIEW: To summarize the data on precision medicine for cervical cancer including the use of potential biomarkers. We also review ongoing areas of research in cervical cancer therapeutics.RECENT FINDINGS: In the current clinical practice, programmed death ligand...
Cite
Manrriquez EN, Zakhour M, Salani R. Precision medicine for cervical cancer. Curr Opin Obstet Gynecol. 2022;34(1):1-5doi: 10.1097/GCO.0000000000000755.
Manrriquez, E. N., Zakhour, M., & Salani, R. (2022). Precision medicine for cervical cancer. Current opinion in obstetrics & gynecology, 34(1), 1-5. https://doi.org/10.1097/GCO.0000000000000755
Manrriquez, Erica N, et al. "Precision medicine for cervical cancer." Current opinion in obstetrics & gynecology vol. 34,1 (2022): 1-5. doi: https://doi.org/10.1097/GCO.0000000000000755
Manrriquez EN, Zakhour M, Salani R. Precision medicine for cervical cancer. Curr Opin Obstet Gynecol. 2022 Feb 01;34(1):1-5. doi: 10.1097/GCO.0000000000000755. PMID: 34596094.
Copy
Download .nbib
Current opinion in obstetrics & gynecology
Henkel A, Beshar I, Goldthwaite LM.
PMID: 34534995
Curr Opin Obstet Gynecol. 2021 Dec 01;33(6):445-452. doi: 10.1097/GCO.0000000000000750.
PURPOSE OF REVIEW: To describe barriers to provision of postpartum permanent contraception at patient, hospital, and insurance levels.RECENT FINDINGS: Permanent contraception remains the most commonly used form of contraception in the United States with the majority of procedures performed...
Cite
Henkel A, Beshar I, Goldthwaite LM. Postpartum permanent contraception: updates on policy and access. Curr Opin Obstet Gynecol. 2021;33(6):445-452doi: 10.1097/GCO.0000000000000750.
Henkel, A., Beshar, I., & Goldthwaite, L. M. (2021). Postpartum permanent contraception: updates on policy and access. Current opinion in obstetrics & gynecology, 33(6), 445-452. https://doi.org/10.1097/GCO.0000000000000750
Henkel, Andrea, et al. "Postpartum permanent contraception: updates on policy and access." Current opinion in obstetrics & gynecology vol. 33,6 (2021): 445-452. doi: https://doi.org/10.1097/GCO.0000000000000750
Henkel A, Beshar I, Goldthwaite LM. Postpartum permanent contraception: updates on policy and access. Curr Opin Obstet Gynecol. 2021 Dec 01;33(6):445-452. doi: 10.1097/GCO.0000000000000750. PMID: 34534995.
Copy
Download .nbib
